成人Fontan通路直径与运动导管检查血流动力学、运动能力及肝脏评分的关联
本研究回顾性分析67例接受运动心导管检查的成人外管道或侧隧道Fontan患者,测量最小通路直径并评估其与血流动力学、运动能力及肝病标志物的关系。结果显示较大直径与运动时肺循环和体循环血流增幅降低及峰值耗氧量占预计值百分比降低独立相关,而与肝病标志物无一致关联。
要点
- 较大Fontan通路直径与运动时肺血流和体循环血流增幅降低独立相关。
- 通路直径每增加1 mm,峰值耗氧量占预计值百分比降低0.8%。
- 通路直径与肝病标志物无一致关联。
核心结论
- 较大Fontan通路直径 paradoxically 与运动时血流增幅受损相关,可能贡献于运动能力降低。
研究设计与样本
- 回顾性研究,纳入67例接受运动心导管检查的成人外管道或侧隧道Fontan患者。
主要发现
- 较大直径与运动时肺血流增幅降低相关(每mm -2.3%;95% CI -3.9至-0.7;P=.005)。
- 较大直径与运动时体循环血流增幅降低相关(每mm -2.2%;95% CI -4.1至-0.2;P=.03)。
- 较大直径与峰值耗氧量占预计值百分比降低相关(每mm -0.8%;95% CI -1.4至-0.2;P=.009),独立于运动平均肺动脉压、肺动脉楔压和峰值心率。
- 通路直径与肝病标志物无一致关联。
- 通路对肝脏造成的压力梯度对静息下腔静脉压力贡献小(0;IQR 0-7.1%),运动时贡献6.4%(IQR 0.5%-14.3%)。
临床怎么用
- 在成人Fontan患者中评估通路直径时,需注意较大直径可能与运动血流动力学和运动能力受损相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The Fontan pathway (inferior vena cava-pulmonary artery connection) regulates forward flow and backward pressure, but its optimal size remains uncertain. This study aimed to evaluate the relationship between Fontan pathway diameter, hemodynamics, exercise capacity, and liver disease markers. METHODS: A retrospective review of 67 adults with extracardiac conduit (EC) or lateral tunnel (LT) Fontan procedures who underwent exercise cardiac catheterization was conducted. Minimal pathway diameter was measured via angiography or computed tomography. Exercise capacity was assessed by percent predicted peak oxygen consumption. Liver disease markers included aspartate aminotransferase-to-platelet ratio, fibrosis-4, and Model for End-Stage Liver Disease excluding international normalized ratio scores. RESULTS: The mean age at catheterization was 30.4 ± 7.9 years. Minimal pathway diameter was 17.5 ± 6.0 mm. Larger diameter was associated with reduced augmentation of pulmonary and systemic blood flow during exercise (pulmonary flow, -2.3% per mm; 95% CI, -3.9 to -0.7; P = .005; systemic flow, -2.2% per mm; 95% CI, -4.1 to -0.2; P = .03), and lower percent predicted peak oxygen consumption (-0.8% per mm; 95% CI, -1.4 to -0.2; P = .009), independent of exercise mean pulmonary artery and pulmonary artery wedge pressures, and peak heart rate. No consistent association was observed between pathway diameter and markers of liver disease. Notably, the pressure gradient on the liver imposed by the pathway contributed minimally to inferior vena cava pressure at rest (0; interquartile range, 0-7.1%) or during exercise (6.4%; interquartile range, 0.5%-14.3%). CONCLUSIONS: Larger Fontan pathway diameter was paradoxically associated with impaired flow augmentation during exercise, which may contribute to reduced exercise capacity.
引用
- Cao JY, Egbe AC, Jain CC, et al. Fontan pathway diameter in adults undergoing exercise catheterization: Association with hemodynamics, exercise capacity, and liver scores. J Thorac Cardiovasc Surg. 2026. PMID: 41780718. doi:10.1016/j.jtcvs.2026.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。